Paper
6 March 2009 Surface-enhanced Raman spectroscopy study of the interaction of antitumoral drug Paclitaxel with human serum albumin
Tianxiu Yan, Huaimin Gu, Xiaojuan Yuan, Jiwei Wu, Huajiang Wei
Author Affiliations +
Abstract
SERS spectroscopy was employed to study the interaction of the antitumoral drug paclitaxel with human serum albumin. The normal Raman spectrum of the paclitaxel was shown in this study for the first time. There were some differences existing in the surface-enhanced Raman scattering (SERS) spectrum of paclitaxel and its human serum albumin (HSA), which demonstrated that there was high bioaffinity of paclitaxel to human serum albumin. And it was also found that there existed some differences in the SERS of the paclitaxel/HSA complexes at different pH values, which may indicated some significant information on the binding site, by which paclitaxel binds to human serum albumin. It can provide significant instruction in the synthesis of the drug and in improving the therapeutic efficacy of this drug.
© (2009) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Tianxiu Yan, Huaimin Gu, Xiaojuan Yuan, Jiwei Wu, and Huajiang Wei "Surface-enhanced Raman spectroscopy study of the interaction of antitumoral drug Paclitaxel with human serum albumin", Proc. SPIE 7280, Seventh International Conference on Photonics and Imaging in Biology and Medicine, 72800N (6 March 2009); https://doi.org/10.1117/12.821462
Lens.org Logo
CITATIONS
Cited by 2 scholarly publications.
Advertisement
Advertisement
RIGHTS & PERMISSIONS
Get copyright permission  Get copyright permission on Copyright Marketplace
KEYWORDS
Surface enhanced Raman spectroscopy

Raman spectroscopy

Silver

Absorption

Metals

Spectrophotometry

Plasmons

Back to Top